Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02GJZ
|
||||
Former ID |
DNAP001686
|
||||
Drug Name |
Ioflupane i-123
|
||||
Synonyms |
Datscan (TN)
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Parkinson's disease [ICD9: 332; ICD10:G20] | Approved | [1] | ||
Company |
GE Healthcare
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C18H23FINO2
|
||||
Canonical SMILES |
COC(=O)C1C2CCC(N2CCCF)CC1C3=CC=C(C=C3)I
|
||||
InChI |
1S/C18H23FINO2/c1-23-18(22)17-15(12-3-5-13(20)6-4-12)11-14-7-8-16(17)21(14)10-2-9-19/h3-6,14-17H,2,7-11H2,1H3/t14?,15-,16?,17+/m1/s1/i20-4
|
||||
InChIKey |
HXWLAJVUJSVENX-PUMJCJFRSA-N
|
||||
CAS Number |
CAS 155798-07-5
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
ChEBI ID |
ChEBI:68855
|
||||
SuperDrug ATC ID |
V09AB03
|
||||
Target and Pathway | |||||
Target(s) | Sodium-dependent dopamine transporter | Target Info | Modulator | [2] | |
KEGG Pathway | Dopaminergic synapse | ||||
Parkinson's disease | |||||
Cocaine addiction | |||||
Amphetamine addiction | |||||
Alcoholism | |||||
PANTHER Pathway | Adrenaline and noradrenaline biosynthesis | ||||
Parkinson disease | |||||
Dopamine receptor mediated signaling pathway | |||||
Pathway Interaction Database | Alpha-synuclein signaling | ||||
Reactome | Na+/Cl- dependent neurotransmitter transporters | ||||
WikiPathways | Monoamine Transport | ||||
NRF2 pathway | |||||
Dopaminergic Neurogenesis | |||||
Parkinsons Disease Pathway | |||||
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | |||||
Neurotransmitter Clearance In The Synaptic Cleft | |||||
References | |||||
REF 1 | 2011 FDA drug approvals. Nat Rev Drug Discov. 2012 Feb 1;11(2):91-4. | ||||
REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.